Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effective therapeutic use of rituximab in refractory Wegener's granulomatosis.

× No keyword cloud information.

14 in total

1. Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.

Authors: C M G Cheung; P I Murray; C O S Savage
Journal: Br J Ophthalmol Date: 2005-11 Impact factor: 4.638

Review 2. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors: D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal: Ann Rheum Dis Date: 2007-11 Impact factor: 19.103

3. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.

Authors: Achille Aouba; Christian Pagnoux; Boris Bienvenu; Alfred Mahr; Loïc Guillevin
Journal: Clin Rev Allergy Immunol Date: 2007-09-12 Impact factor: 8.667

Review 4. Targeted biologic approaches to the treatment of systemic vasculitis.

Authors: Andreea Coca; Jennifer H Anolik
Journal: Clin Rev Allergy Immunol Date: 2008-10 Impact factor: 8.667

Review 5. Risk factors for treatment failures in antineutrophil cytoplasmic antibody- associated small-vessel vasculitis.

Authors: Vijay R Karia; Luis R Espinoza
Journal: Curr Rheumatol Rep Date: 2009-12 Impact factor: 4.592

Review 6. [Wegener's granulomatosis and microscopic polyangiitis].

Authors: K de Groot; E Reinhold-Keller
Journal: Z Rheumatol Date: 2009-02 Impact factor: 1.372

7. Effectiveness of rituximab in severe Wegener's granulomatosis: report of two cases and review of the literature.

Authors: Joaquim Oristrell; Guillermina Bejarano; Rosa Jordana; Manuel Monteagudo; Begoña Marí; Arnau Casanovas; Carles Tolosa
Journal: Open Respir Med J Date: 2009-06-25

8. Successful Treatment of ANCA-Negative Wegener's Granulomatosis with Rituximab.

Authors: Afsha Khan; Catherine A Lawson; Mark A Quinn; Amanda H Isdale; Michael J Green
Journal: Int J Rheumatol Date: 2010-10-26

Review 9. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors: Richard W Lee; David P D'Cruz
Journal: Drugs Date: 2008 Impact factor: 9.546

Review 10. Treatment of renal manifestations of ANCA-associated vasculitis.

Authors: Kresimir Galesic; Danica Ljubanovic; Ivica Horvatic
Journal: J Nephropathol Date: 2013-01-01